Antibacterial activity of ZnO nanoparticle suspensions on a broad spectrum of microorganisms

被引:1339
作者
Jones, Nicole [1 ]
Ray, Binata [1 ]
Ranjit, Koodali T. [2 ]
Manna, Adhar C. [1 ,3 ]
机构
[1] Univ S Dakota, Sanford Sch Med, Div Basic Biomed Sci, Vermillion, SD 57069 USA
[2] Univ S Dakota, Dept Chem, Vermillion, SD 57069 USA
[3] S Dakota State Univ, Ctr Infect Dis Res & Vaccinol, Brookings, SD 57007 USA
关键词
ZnO nanoparticles; antibacterial; Staphylococcus aureus;
D O I
10.1111/j.1574-6968.2007.01012.x
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
Nanoparticle metal oxides represent a new class of important materials that are increasingly being developed for use in research and health-related applications. Highly ionic metal oxides are interesting not only for their wide variety of physical and chemical properties but also for their antibacterial activity. Although the in vitro antibacterial activity and efficacy of regular zinc oxides have been investigated, little is known about the antibacterial activity of nanoparticles of ZnO. Preliminary growth analysis data suggest that nanoparticles of ZnO have significantly higher antibacterial effects on Staphylococcus aureus than do five other metal oxide nanoparticles. In addition, studies have clearly demonstrated that ZnO nanoparticles have a wide range of antibacterial effects on a number of other microorganisms. The antibacterial activity of ZnO may be dependent on the size and the presence of normal visible light. The data suggest that ZnO nanoparticles have a potential application as a bacteriostatic agent in visible light and may have future applications in the development of derivative agents to control the spread and infection of a variety of bacterial strains.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 30 条
[1]
Deposition of CTAB-terminated nanorods on bacteria to form highly conducting hybrid systems [J].
Berry, V ;
Gole, A ;
Kundu, S ;
Murphy, CJ ;
Saraf, RF .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (50) :17600-17601
[2]
BOYCE JM, 1997, STAPHYLOCOCCI HUMAN, P309, DOI DOI 10.1002/9781444308464.CH15
[3]
Toxicological impact studies based on Escherichia coli bacteria in ultrafine ZnO nanoparticles colloidal medium [J].
Brayner, R ;
Ferrari-Iliou, R ;
Brivois, N ;
Djediat, S ;
Benedetti, MF ;
Fiévet, F .
NANO LETTERS, 2006, 6 (04) :866-870
[4]
Copper nanoparticle/polymer composites with antifungal and bacteriostatic properties [J].
Cioffi, N ;
Torsi, L ;
Ditaranto, N ;
Tantillo, G ;
Ghibelli, L ;
Sabbatini, L ;
Bleve-Zacheo, T ;
D'Alessio, M ;
Zambonin, PG ;
Traversa, E .
CHEMISTRY OF MATERIALS, 2005, 17 (21) :5255-5262
[5]
Emerging and re-emerging infectious diseases [J].
Desselberger, U .
JOURNAL OF INFECTION, 2000, 40 (01) :3-15
[6]
Silver nanoparticles and polymeric medical devices: a new approach to prevention of infection? [J].
Furno, F ;
Morley, KS ;
Wong, B ;
Sharp, BL ;
Arnold, PL ;
Howdle, SM ;
Bayston, R ;
Brown, PD ;
Winship, PD ;
Reid, HJ .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 54 (06) :1019-1024
[7]
Identification of a zinc-specific metalloregulatory protein, Zur, controlling zinc transport operons in Bacillus subtilis [J].
Gaballa, A ;
Helmann, JD .
JOURNAL OF BACTERIOLOGY, 1998, 180 (22) :5815-5821
[8]
Hancock LE, 2000, GRAM-POSITIVE PATHOGENS, P251
[9]
Ag/AgBr/TiO2 visible light photocatalyst for destruction of azodyes and bacteria [J].
Hu, C ;
Lan, YQ ;
Qu, JH ;
Hu, XX ;
Wang, AM .
JOURNAL OF PHYSICAL CHEMISTRY B, 2006, 110 (09) :4066-4072
[10]
Nanoscale powders and formulations with biocidal activity toward spores and vegetative cells of Bacillus species, viruses, and toxins [J].
Koper, OB ;
Klabunde, JS ;
Marchin, GL ;
Klabunde, KJ ;
Stoimenov, P ;
Bohra, L .
CURRENT MICROBIOLOGY, 2002, 44 (01) :49-55